Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe latest revision tag in the history is updated to v3.5.4, replacing the previous v3.5.3 tag.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s software revision marker was updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than a modification to the trial’s record history.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a new record version v3.5.0 and removed v3.4.3 from the history.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check100 days agoChange DetectedAdded Revision: v3.4.2 to the history log and removed older notices including the lapse in government funding message and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.